Skip to content
June 18, 2026

September 3, 2026: pre-ISUOG IOTA day - using ultrasound to diagnose gynaecological cancer

TYPE
TYPE
ISUOG approved course
Date
Date
September 3, 2026
Location
Location
ExCel London, 1 Western Gateway, London E16 1XL, United Kingdom
Contact
Contact
support@gynaia.com
Contact person
Contact person
Hilde Verduyckt
ExCel London - ISUOG endorsed IOTA course

 

Using ultrasound to diagnose gynaecological cancer

What you need to know to run an effective rapid access clinic

 

Rather than focusing on research or advanced theory, this course focuses on the practical realities of implementing ultrasound-based diagnostics in routine clinical care, making it relevant for gynaecologists, sonographers, trainees, and anyone involved in diagnostic pathways.

Organized by the IOTA consortium, this course brings together clinicians who use and teach these diagnostic approaches every day, and spans ovarian mass assessment, PMB evaluation, cancer risk stratification, tumour spread assessment, and the practical implementation of effective diagnostic pathways, including rapid access clinics. 


About the course

The full-day programme covers three core areas: starting off with a comprehensive review of ovarian pathology; from IOTA terminology and benign descriptors to the ADNEX model and its 2-step strategy, illustrated with case examples.

The day continues with endometrial pathology, including how to describe the endometrium using the IETA approach. A dedicated session on myometrial pathology follows, including adenomyosis, fibroids, and sarcoma red flags.

The programme wraps up with a forward-looking session on AI in clinical practice, including ADNEX AI, alongside practical lessons from the ROCKETS trial and guidance on common management dilemmas.

Additional sessions address ovarian masses in pregnancy, ovarian pathology in adolescents, assessment of tumour spread in suspected malignancy, and practical implementation lessons.

A lunch lecture by Gynaia explores how gynaecology-specific reporting tools and smart image analysis can reshape workflows in rapid access clinics. 

 

Pricing

Includes on-site attendance to the full-day programme, catered lunch and breaks, and a 1-year Gynaia-IOTA Ovarian membership with learning materials, certification exam, webinars, education tools, and the ADNEX app.

Standard price: 295£ / 340€

 

Discount price: 195£ / 225€ 

Please choose this discounted rate if you:

  • have ever been IOTA certified

  • are a current Gynaia member (Ovarian/IOTA, Uterine/IOTA-IETA, Endometriosis/IDEA, or Early pregnancy)

  • work within the NHS (have an NHS e-mail address)

  • are an early career professional (e.g. student, resident, PhD researcher)

  • GREEG members (France)

  • hail from low and lower-middle income countries (list)

 

Programme

View detailed programme

September 3, 2026

08:55

 Welcome and introduction  

Dirk Timmerman, KU Leuven

Current Management: evaluating women with a possible ovarian mass:
The classification of ovarian pathology

Chairs: Misty Blanchette-Porter, University of Vermont and Juan-Luis Alcazar, University of Navarra, Pamplona

09:00 

IOTA Terms and Definitions: making sure we all use the same nomenclature to describe ovarian masses including the 2026 update

 

Agnieszka Kotlarz, Kraków University Medical College

09:20

IOTA Benign Descriptors and pattern recognition for less common masses  

Ligita Jokubkiene, Malmö, Lund University 

09:40

The IOTA ADNEX model, the features you need to recognise to use it, test performance and the 2-step strategy 

Dirk Timmerman, KU Leuven

 

10:10

Case examples using IOTA ADNEX and the 2-step strategy to characterise ovarian pathology 

Antonia Testa and Francesca Moro, Gemelli Hospital, Rome

 

10:40

Coffee Break

 

Ovarian pathology - specific scenarios 

Chairs: Gàbor Szabo, Semmelweis University, Budapest and Ligita Jokubkiene, Malmö, Lund University  

11:10

Managing ovarian masses in pregnancy including decidualisation

Nina Cooper, Imperial College, London

11:20

Classification and management of ovarian cysts in paediatric and adolescent population

Maya Al Memar, Imperial College, London

11:40

The features of less common ovarian cysts. Pattern recognition and the imaging in gynaecology series

Antonia Testa, Gemelli Hospital, Rome 

12:00

Case examples of less common masses, cysts in pregnancy and in young women

Francesca Moro, Gemelli Hospital, Rome and Nina Cooper, Imperial College London

12:30

Lunch - Industry session with Gynaia - The future - How AI may impact on workflow in a rapid access cancer diagnostic clinic (Gynaia sponsored lecture) 

Dirk Timmerman, KU Leuven

Evaluating women with possible endometrial pathology including PMB

Chairs:  Inessa Safonova, University of Kharkiv and Antonia Testa, Gemelli Hospital Rome 

13:30

Measuring the endometrium, interpreting endometrial thickness and how to describe endometrial pathology using the IETA approach 

Thierry Van den Bosch, KU Leuven

13:50

Investigating the endometrium in women taking HRT or Tamoxifen  

Juan Luis Alcazar, University of Navarra, Spain

14:10

Using Saline or Gel to outline the endometrial cavity to diagnose focal pathology and when and how best to take an endometrial biopsy 

Thierry Van den Bosch, KU Leuven, Belgium

14:30

Case examples of endometrial pathology

Gàbor Szabo, Semmelweis University, Budapest 

 15:00

Coffee Break 

 

 

Myometrial pathology and AI

Chairs: Thierry Van den Bosch, KU Leuven, Belgium and Valentina Chiappa, Istituto Nazionale dei Tumori Milan 

15:30

Defining myometrial pathology: adenomyosis, fibroids and sarcoma - when should you be concerned?

Stefan Timmerman, Jessa Hospital, Hasselt, Belgium

15:50

AI and classifying ovarian cysts - from Radiomics to ADNEX AI - when will these start to feature in your clinical practice? 

Jen Barcroft, Imperial College London

Practical management of the clinic

 

 

16:10

Practical lessons learnt from the ROCKETS trial - implementing the use of the IOTA ADNEX model in your clinical practice

Vivian Do, University of Birmingham  

16:30

What about looking for tumour spread – what can you report on in a patient when you identify a probable cancer in the rapid access clinic?

Daniela Fischerová, Charles University, Prague 

17:00

Common management problems - What to do when a CA-125 is elevated by the scan is normal? When does a woman with PMB need to be investigated if she bleeds again? How long do you need to follow up ovarian cysts?

Joseph Yazbek, Imperial College London

17:30

Close of Meeting

 

Invited Faculty

Dirk Timmerman
Dirk Timmerman

 KU Leuven, Belgium

Misty Blanchette-Porter
Misty Blanchette-Porter

University of Vermont

Juan Luis Alcazar
Juan Luis Alcazar

 University of Navarra, Spain 

Ligita Jokubkiene
Ligita Jokubkiene

Malmö, Lund University 

Antonia Testa
Antonia Testa

Gemelli Hospital, Rome

Gàbor Szabo
Gàbor Szabo

Semmelweis University, Budapest

Nina Cooper
Nina Cooper

Imperial College London 

Francesca Moro
Francesca Moro

Gemelli Hospital, Rome 

Thierry Van den Bosch
Thierry Van den Bosch

KU Leuven, Belgium

Valentina Chiappa
Valentina Chiappa

Istituto Nazionale dei Tumori Milan

Stefan Timmerman
Stefan Timmerman

Jessa Hospital, Hasselt, Belgium

Jen Barcroft
Jen Barcroft

Imperial College London

Joseph Yazbek
Joseph Yazbek

Imperial College London 

Maya Al Memar
Maya Al Memar

Imperial College London 

Vivian Do
Vivian Do

University of Birmingham 

Inessa Safonova
Inessa Safonova

University of Kharkiv

Agnieszka Kotlarz
Agnieszka Kotlarz

Kraków University Medical College

Daniela Fischerová
Daniela Fischerová

Charles University, Prague, Czech Republic

September 3, 2026